

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.62444779 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.62444779 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.58929277 |
| 4 | viral transcription (GO:0019083) | 4.45934986 |
| 5 | mesenchymal-epithelial cell signaling (GO:0060638) | 4.45894456 |
| 6 | membrane raft organization (GO:0031579) | 4.45816856 |
| 7 | chondrocyte proliferation (GO:0035988) | 4.43778030 |
| 8 | translational termination (GO:0006415) | 4.29701177 |
| 9 | immunoglobulin mediated immune response (GO:0016064) | 4.28756602 |
| 10 | response to peptidoglycan (GO:0032494) | 4.12275904 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.10526429 |
| 12 | wound healing, spreading of epidermal cells (GO:0035313) | 4.07830497 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.06921254 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.05875008 |
| 15 | regulation of protein heterodimerization activity (GO:0043497) | 3.98458569 |
| 16 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 3.96857636 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.81879071 |
| 18 | cellular response to interferon-alpha (GO:0035457) | 3.80411096 |
| 19 | myeloid cell homeostasis (GO:0002262) | 3.79881235 |
| 20 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.78854785 |
| 21 | outer ear morphogenesis (GO:0042473) | 3.75600484 |
| 22 | wound healing, spreading of cells (GO:0044319) | 3.74334167 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 3.73603271 |
| 24 | protein targeting to ER (GO:0045047) | 3.72001829 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.69799141 |
| 26 | ribosomal small subunit biogenesis (GO:0042274) | 3.67971766 |
| 27 | cell adhesion mediated by integrin (GO:0033627) | 3.66438236 |
| 28 | cotranslational protein targeting to membrane (GO:0006613) | 3.65597881 |
| 29 | regulation of tight junction assembly (GO:2000810) | 3.63781245 |
| 30 | translational elongation (GO:0006414) | 3.59855525 |
| 31 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.56790242 |
| 32 | detection of other organism (GO:0098543) | 3.56660999 |
| 33 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.56556248 |
| 34 | granulocyte activation (GO:0036230) | 3.55112432 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.53159865 |
| 36 | collagen fibril organization (GO:0030199) | 3.49132531 |
| 37 | neutrophil activation (GO:0042119) | 3.48517385 |
| 38 | detection of bacterium (GO:0016045) | 3.48422710 |
| 39 | protein localization to endoplasmic reticulum (GO:0070972) | 3.46347931 |
| 40 | viral life cycle (GO:0019058) | 3.45375431 |
| 41 | mature B cell differentiation involved in immune response (GO:0002313) | 3.45305709 |
| 42 | regulation of T cell tolerance induction (GO:0002664) | 3.44865754 |
| 43 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.43183060 |
| 44 | middle ear morphogenesis (GO:0042474) | 3.42968847 |
| 45 | macrophage activation involved in immune response (GO:0002281) | 3.42405458 |
| 46 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.42273694 |
| 47 | cellular protein complex disassembly (GO:0043624) | 3.41200313 |
| 48 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.33726950 |
| 49 | platelet aggregation (GO:0070527) | 3.32963809 |
| 50 | apoptotic cell clearance (GO:0043277) | 3.32472168 |
| 51 | leukocyte aggregation (GO:0070486) | 3.32149956 |
| 52 | respiratory burst (GO:0045730) | 3.31420367 |
| 53 | cellular response to type I interferon (GO:0071357) | 3.30416960 |
| 54 | type I interferon signaling pathway (GO:0060337) | 3.30416960 |
| 55 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.28966600 |
| 56 | B cell mediated immunity (GO:0019724) | 3.27715508 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.27485807 |
| 58 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.26687679 |
| 59 | endodermal cell differentiation (GO:0035987) | 3.26078486 |
| 60 | response to type I interferon (GO:0034340) | 3.24838184 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.23619476 |
| 62 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.22467439 |
| 63 | cortical actin cytoskeleton organization (GO:0030866) | 3.20784562 |
| 64 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.20369362 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 3.20147322 |
| 66 | regulation of early endosome to late endosome transport (GO:2000641) | 3.18782430 |
| 67 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.17811758 |
| 68 | positive regulation of B cell differentiation (GO:0045579) | 3.17708128 |
| 69 | T cell migration (GO:0072678) | 3.16229737 |
| 70 | regulation of tolerance induction (GO:0002643) | 3.13830028 |
| 71 | response to interferon-beta (GO:0035456) | 3.12647811 |
| 72 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.12330438 |
| 73 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.12024769 |
| 74 | detection of external biotic stimulus (GO:0098581) | 3.11663967 |
| 75 | positive regulation of mast cell activation (GO:0033005) | 3.09688535 |
| 76 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.09487241 |
| 77 | regulation of gamma-delta T cell activation (GO:0046643) | 3.08697964 |
| 78 | dermatan sulfate biosynthetic process (GO:0030208) | 3.08543488 |
| 79 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.07728897 |
| 80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07298569 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07006882 |
| 82 | protein targeting to plasma membrane (GO:0072661) | 3.06294801 |
| 83 | positive regulation of actin filament depolymerization (GO:0030836) | 3.03376643 |
| 84 | translational initiation (GO:0006413) | 3.02708750 |
| 85 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02593678 |
| 86 | positive regulation of mast cell degranulation (GO:0043306) | 3.02593678 |
| 87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.00338329 |
| 88 | protein targeting to membrane (GO:0006612) | 2.99982818 |
| 89 | positive thymic T cell selection (GO:0045059) | 2.99444175 |
| 90 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.98599276 |
| 91 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.97558712 |
| 92 | regulation of metalloenzyme activity (GO:0048552) | 2.94650770 |
| 93 | membrane budding (GO:0006900) | 2.93919579 |
| 94 | skin morphogenesis (GO:0043589) | 2.93745027 |
| 95 | lymphocyte chemotaxis (GO:0048247) | 2.93698453 |
| 96 | detection of molecule of bacterial origin (GO:0032490) | 2.92733770 |
| 97 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.90607155 |
| 98 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.90172610 |
| 99 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.89084407 |
| 100 | barbed-end actin filament capping (GO:0051016) | 2.88304963 |
| 101 | NIK/NF-kappaB signaling (GO:0038061) | 2.87525581 |
| 102 | ribosomal small subunit assembly (GO:0000028) | 2.87222905 |
| 103 | regulation of mononuclear cell migration (GO:0071675) | 2.87068434 |
| 104 | protein heterotrimerization (GO:0070208) | 2.86854558 |
| 105 | regulation of histone phosphorylation (GO:0033127) | 2.86749223 |
| 106 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.85825917 |
| 107 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.85380623 |
| 108 | regulation of vitamin metabolic process (GO:0030656) | 2.83648695 |
| 109 | positive regulation of interferon-alpha production (GO:0032727) | 2.83165385 |
| 110 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.82153786 |
| 111 | natural killer cell mediated immunity (GO:0002228) | 2.82153786 |
| 112 | cortical cytoskeleton organization (GO:0030865) | 2.81583227 |
| 113 | dermatan sulfate metabolic process (GO:0030205) | 2.80899672 |
| 114 | regulation of mast cell activation (GO:0033003) | 2.80561452 |
| 115 | regulation of leukocyte degranulation (GO:0043300) | 2.79827580 |
| 116 | actin filament depolymerization (GO:0030042) | 2.79253466 |
| 117 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.78637988 |
| 118 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.78077648 |
| 119 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.77883335 |
| 120 | peptidyl-proline hydroxylation (GO:0019511) | 2.77309799 |
| 121 | cellular extravasation (GO:0045123) | 2.77256699 |
| 122 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.76588840 |
| 123 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.76588840 |
| 124 | positive regulation of tolerance induction (GO:0002645) | 2.76544951 |
| 125 | T cell apoptotic process (GO:0070231) | 2.76520799 |
| 126 | leukocyte degranulation (GO:0043299) | 2.75779178 |
| 127 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.75256114 |
| 128 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.74567099 |
| 129 | regulation of antigen processing and presentation (GO:0002577) | 2.74248067 |
| 130 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.73933884 |
| 131 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.72489950 |
| 132 | cytidine deamination (GO:0009972) | 2.72292777 |
| 133 | cytidine metabolic process (GO:0046087) | 2.72292777 |
| 134 | cytidine catabolic process (GO:0006216) | 2.72292777 |
| 135 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.71980663 |
| 136 | positive regulation of antigen processing and presentation (GO:0002579) | 2.71455008 |
| 137 | protein complex disassembly (GO:0043241) | 2.71075564 |
| 138 | detection of biotic stimulus (GO:0009595) | 2.70780445 |
| 139 | low-density lipoprotein particle clearance (GO:0034383) | 2.70240265 |
| 140 | myeloid dendritic cell activation (GO:0001773) | 2.69578121 |
| 141 | actin nucleation (GO:0045010) | 2.69391360 |
| 142 | cellular response to arsenic-containing substance (GO:0071243) | 2.68701355 |
| 143 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.68147793 |
| 144 | negative regulation of innate immune response (GO:0045824) | 2.67151618 |
| 145 | negative T cell selection (GO:0043383) | 2.66338301 |
| 146 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.66223336 |
| 147 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.66223336 |
| 148 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.66223336 |
| 149 | modulation by symbiont of host immune response (GO:0052553) | 2.66223336 |
| 150 | positive regulation by symbiont of host defense response (GO:0052509) | 2.66223336 |
| 151 | modulation by symbiont of host defense response (GO:0052031) | 2.66223336 |
| 152 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.66127532 |
| 153 | myeloid dendritic cell differentiation (GO:0043011) | 2.65316626 |
| 154 | amino sugar catabolic process (GO:0046348) | 2.64919088 |
| 155 | response to interferon-alpha (GO:0035455) | 2.64717041 |
| 156 | cellular defense response (GO:0006968) | 2.64279373 |
| 157 | regulation of interferon-alpha production (GO:0032647) | 2.63773747 |
| 158 | pinocytosis (GO:0006907) | 2.63762873 |
| 159 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.63428693 |
| 160 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.62939447 |
| 161 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.62684612 |
| 162 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.61717453 |
| 163 | microglial cell activation (GO:0001774) | 2.61471275 |
| 164 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.60567006 |
| 165 | mast cell activation (GO:0045576) | 2.60485508 |
| 166 | mature B cell differentiation (GO:0002335) | 2.59395130 |
| 167 | regulation of B cell differentiation (GO:0045577) | 2.59350359 |
| 168 | protein retention in ER lumen (GO:0006621) | 2.59267947 |
| 169 | defense response to protozoan (GO:0042832) | 2.57287890 |
| 170 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57257919 |
| 171 | regulation of lymphocyte migration (GO:2000401) | 2.56680592 |
| 172 | DNA deamination (GO:0045006) | 2.55263000 |
| 173 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.55232337 |
| 174 | metanephric mesenchyme development (GO:0072075) | 2.54023577 |
| 175 | fibril organization (GO:0097435) | 2.53903986 |
| 176 | myeloid leukocyte activation (GO:0002274) | 2.53574048 |
| 177 | regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516) | 2.52123612 |
| 178 | cellular response to vitamin (GO:0071295) | 2.51928159 |
| 179 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.50428261 |
| 180 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.49341472 |
| 181 | macromolecular complex disassembly (GO:0032984) | 2.48646795 |
| 182 | response to laminar fluid shear stress (GO:0034616) | 2.48461736 |
| 183 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.43371660 |
| 184 | localization within membrane (GO:0051668) | 2.43193478 |
| 185 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.43137478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.14219490 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.86876244 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.61916587 |
| 4 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.03391132 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.73913931 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.15246057 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.94515685 |
| 8 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.92205651 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.88420374 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.75366303 |
| 11 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.69674426 |
| 12 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.62488981 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.58178391 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.52490646 |
| 15 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.50971622 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.46347745 |
| 17 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.45317076 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.41218461 |
| 19 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.38788657 |
| 20 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.31265639 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.21908978 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.15351499 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.13394031 |
| 24 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.08925876 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05335456 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02433461 |
| 27 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.02260281 |
| 28 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.02260281 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.98683150 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96083283 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.95876097 |
| 32 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.92912001 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91296758 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.88848328 |
| 35 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.87206296 |
| 36 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.86442810 |
| 37 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.86393023 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.85278950 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.83519643 |
| 40 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.79587257 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.79587257 |
| 42 | CJUN_26792858_Chip-Seq_BT549_Human | 1.78625727 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77473745 |
| 44 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76654035 |
| 45 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75853198 |
| 46 | ATF3_27146783_Chip-Seq_COLON_Human | 1.74352119 |
| 47 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.73783907 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73732594 |
| 49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.73022947 |
| 50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71159913 |
| 51 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.66385983 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.66385899 |
| 53 | * MYB_26560356_Chip-Seq_TH1_Human | 1.64903648 |
| 54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.63903424 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62005127 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62003412 |
| 57 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.59660175 |
| 58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.57180747 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57074501 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51940857 |
| 61 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51550614 |
| 62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47361477 |
| 63 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.46868642 |
| 64 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.46374515 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.44363034 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44216185 |
| 67 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42143699 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.41794807 |
| 69 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.39961401 |
| 70 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36579257 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36022170 |
| 72 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.35834471 |
| 73 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35367995 |
| 74 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35099674 |
| 75 | MYC_22102868_ChIP-Seq_BL_Human | 1.34723668 |
| 76 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.34136633 |
| 77 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.33739633 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31305549 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30712818 |
| 80 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30451680 |
| 81 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30025003 |
| 82 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29724429 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28013240 |
| 84 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.26657699 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26051820 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25662075 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24090407 |
| 88 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.23181619 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22907008 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22368162 |
| 91 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22298561 |
| 92 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21779397 |
| 93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.21741881 |
| 94 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21344927 |
| 95 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20910595 |
| 96 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20502891 |
| 97 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20438631 |
| 98 | * MAF_26560356_Chip-Seq_TH1_Human | 1.19577294 |
| 99 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16904127 |
| 100 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16757859 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16375561 |
| 102 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15389842 |
| 103 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.15112685 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14630942 |
| 105 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14259452 |
| 106 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13666926 |
| 107 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13142050 |
| 108 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10236719 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09514409 |
| 110 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07602133 |
| 111 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06854570 |
| 112 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06622046 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06210051 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06019869 |
| 115 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05372782 |
| 116 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03972369 |
| 117 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03787362 |
| 118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03215875 |
| 119 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02902883 |
| 120 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02212424 |
| 121 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.01486875 |
| 122 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01406796 |
| 123 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00852202 |
| 124 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00751540 |
| 125 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99233902 |
| 126 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99164252 |
| 127 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.98732255 |
| 128 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97676365 |
| 129 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.97061329 |
| 130 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96645081 |
| 131 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96235430 |
| 132 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.96105118 |
| 133 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94710572 |
| 134 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94243252 |
| 135 | * MYB_26560356_Chip-Seq_TH2_Human | 0.94068285 |
| 136 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93606152 |
| 137 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93311191 |
| 138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93227967 |
| 139 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92584137 |
| 140 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92465055 |
| 141 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.91927846 |
| 142 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91513888 |
| 143 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91180748 |
| 144 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.90558214 |
| 145 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89791524 |
| 146 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.89557793 |
| 147 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86000608 |
| 148 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.85818021 |
| 149 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85052403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 6.00356547 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 5.34172926 |
| 3 | MP0003279_aneurysm | 3.53406098 |
| 4 | MP0005671_abnormal_response_to | 3.37566818 |
| 5 | MP0005275_abnormal_skin_tensile | 3.28922532 |
| 6 | MP0005503_abnormal_tendon_morphology | 2.94911403 |
| 7 | MP0001958_emphysema | 2.67414151 |
| 8 | MP0009384_cardiac_valve_regurgitation | 2.57728946 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.51076322 |
| 10 | MP0003436_decreased_susceptibility_to | 2.37446746 |
| 11 | MP0000750_abnormal_muscle_regeneration | 2.22299352 |
| 12 | MP0003091_abnormal_cell_migration | 2.22044113 |
| 13 | MP0005023_abnormal_wound_healing | 2.21191806 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.09667287 |
| 15 | MP0003303_peritoneal_inflammation | 2.07005576 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.02724763 |
| 17 | MP0003763_abnormal_thymus_physiology | 1.94630673 |
| 18 | MP0010030_abnormal_orbit_morphology | 1.93803020 |
| 19 | MP0005257_abnormal_intraocular_pressure | 1.88467308 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 1.87979038 |
| 21 | MP0005076_abnormal_cell_differentiation | 1.77185831 |
| 22 | MP0000858_altered_metastatic_potential | 1.76106516 |
| 23 | MP0001542_abnormal_bone_strength | 1.74416809 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.73610436 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.73514877 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.67667428 |
| 27 | MP0000733_abnormal_muscle_development | 1.64647896 |
| 28 | MP0005623_abnormal_meninges_morphology | 1.63812811 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.62320859 |
| 30 | MP0000716_abnormal_immune_system | 1.61913111 |
| 31 | MP0000343_altered_response_to | 1.60336180 |
| 32 | MP0008469_abnormal_protein_level | 1.59489258 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.58674942 |
| 34 | MP0002060_abnormal_skin_morphology | 1.58371505 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.56973664 |
| 36 | MP0001243_abnormal_dermal_layer | 1.53902558 |
| 37 | MP0002398_abnormal_bone_marrow | 1.52699760 |
| 38 | MP0005508_abnormal_skeleton_morphology | 1.50976570 |
| 39 | MP0005390_skeleton_phenotype | 1.48410544 |
| 40 | MP0002933_joint_inflammation | 1.46360853 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.45380364 |
| 42 | MP0000604_amyloidosis | 1.44618625 |
| 43 | MP0006054_spinal_hemorrhage | 1.41779315 |
| 44 | MP0009785_altered_susceptibility_to | 1.38552232 |
| 45 | MP0006082_CNS_inflammation | 1.38542927 |
| 46 | MP0005166_decreased_susceptibility_to | 1.38034190 |
| 47 | MP0008260_abnormal_autophagy | 1.35599680 |
| 48 | MP0003448_altered_tumor_morphology | 1.34641728 |
| 49 | MP0002419_abnormal_innate_immunity | 1.33810371 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.32762156 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.32582744 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.32509013 |
| 53 | MP0002429_abnormal_blood_cell | 1.31869715 |
| 54 | MP0002722_abnormal_immune_system | 1.29511111 |
| 55 | MP0004272_abnormal_basement_membrane | 1.28221542 |
| 56 | MP0002295_abnormal_pulmonary_circulatio | 1.24456535 |
| 57 | MP0004947_skin_inflammation | 1.22881550 |
| 58 | MP0009379_abnormal_foot_pigmentation | 1.21942511 |
| 59 | MP0000685_abnormal_immune_system | 1.20691063 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.20472153 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.18421623 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.18382959 |
| 63 | MP0001299_abnormal_eye_distance/ | 1.17818429 |
| 64 | MP0004510_myositis | 1.17712884 |
| 65 | MP0002896_abnormal_bone_mineralization | 1.17455920 |
| 66 | MP0003866_abnormal_defecation | 1.15716913 |
| 67 | MP0005165_increased_susceptibility_to | 1.14950704 |
| 68 | MP0001873_stomach_inflammation | 1.13908427 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.13496602 |
| 70 | MP0002452_abnormal_antigen_presenting | 1.11662499 |
| 71 | MP0009250_abnormal_appendicular_skeleto | 1.11651003 |
| 72 | MP0001835_abnormal_antigen_presentation | 1.09278113 |
| 73 | MP0003795_abnormal_bone_structure | 1.08742330 |
| 74 | MP0002405_respiratory_system_inflammati | 1.07719674 |
| 75 | MP0004883_abnormal_blood_vessel | 1.05488681 |
| 76 | MP0005451_abnormal_body_composition | 1.05288770 |
| 77 | MP0005164_abnormal_response_to | 1.04799037 |
| 78 | MP0010307_abnormal_tumor_latency | 1.03240269 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 1.03139973 |
| 80 | MP0003724_increased_susceptibility_to | 1.03075661 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 1.00249624 |
| 82 | MP0009763_increased_sensitivity_to | 1.00045538 |
| 83 | MP0000163_abnormal_cartilage_morphology | 0.99784941 |
| 84 | MP0001879_abnormal_lymphatic_vessel | 0.98564978 |
| 85 | MP0001348_abnormal_lacrimal_gland | 0.98142087 |
| 86 | MP0002282_abnormal_trachea_morphology | 0.96109861 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.95859763 |
| 88 | MP0005025_abnormal_response_to | 0.93934529 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.93666937 |
| 90 | MP0005387_immune_system_phenotype | 0.92825374 |
| 91 | MP0001790_abnormal_immune_system | 0.92825374 |
| 92 | MP0000767_abnormal_smooth_muscle | 0.91347216 |
| 93 | MP0005197_abnormal_uvea_morphology | 0.91321550 |
| 94 | MP0002723_abnormal_immune_serum | 0.89755904 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.89032525 |
| 96 | MP0002113_abnormal_skeleton_development | 0.88751020 |
| 97 | MP0001853_heart_inflammation | 0.87686002 |
| 98 | MP0002006_tumorigenesis | 0.87200957 |
| 99 | MP0002115_abnormal_skeleton_extremities | 0.86377478 |
| 100 | MP0002132_abnormal_respiratory_system | 0.85855824 |
| 101 | MP0001819_abnormal_immune_cell | 0.85254096 |
| 102 | MP0001851_eye_inflammation | 0.84382388 |
| 103 | MP0002420_abnormal_adaptive_immunity | 0.84112006 |
| 104 | MP0005310_abnormal_salivary_gland | 0.83121934 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.82562974 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.81612822 |
| 107 | MP0002277_abnormal_respiratory_mucosa | 0.80843391 |
| 108 | MP0002177_abnormal_outer_ear | 0.80372827 |
| 109 | MP0003690_abnormal_glial_cell | 0.80135035 |
| 110 | MP0009278_abnormal_bone_marrow | 0.79831301 |
| 111 | MP0002168_other_aberrant_phenotype | 0.77670740 |
| 112 | MP0001800_abnormal_humoral_immune | 0.76120635 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.75914422 |
| 114 | MP0001663_abnormal_digestive_system | 0.75846493 |
| 115 | MP0000759_abnormal_skeletal_muscle | 0.75688105 |
| 116 | MP0008004_abnormal_stomach_pH | 0.74530545 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.71722781 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.71561932 |
| 119 | MP0000249_abnormal_blood_vessel | 0.71450356 |
| 120 | MP0004233_abnormal_muscle_weight | 0.71381550 |
| 121 | MP0003075_altered_response_to | 0.71052995 |
| 122 | MP0000490_abnormal_crypts_of | 0.70600388 |
| 123 | MP0000627_abnormal_mammary_gland | 0.69449861 |
| 124 | MP0009764_decreased_sensitivity_to | 0.68154279 |
| 125 | MP0000049_abnormal_middle_ear | 0.67916303 |
| 126 | MP0009840_abnormal_foam_cell | 0.67747012 |
| 127 | MP0003186_abnormal_redox_activity | 0.67307881 |
| 128 | MP0005595_abnormal_vascular_smooth | 0.67131195 |
| 129 | MP0003329_amyloid_beta_deposits | 0.66028258 |
| 130 | MP0003828_pulmonary_edema | 0.65613461 |
| 131 | MP0001545_abnormal_hematopoietic_system | 0.65214446 |
| 132 | MP0005397_hematopoietic_system_phenotyp | 0.65214446 |
| 133 | MP0000681_abnormal_thyroid_gland | 0.64816089 |
| 134 | MP0000428_abnormal_craniofacial_morphol | 0.64695800 |
| 135 | MP0000920_abnormal_myelination | 0.62860921 |
| 136 | MP0003183_abnormal_peptide_metabolism | 0.62428294 |
| 137 | MP0005319_abnormal_enzyme/_coenzyme | 0.60050389 |
| 138 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.57761020 |
| 139 | MP0008874_decreased_physiological_sensi | 0.57459796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 7.41478093 |
| 2 | Premature rupture of membranes (HP:0001788) | 6.90924637 |
| 3 | Vertebral compression fractures (HP:0002953) | 5.27879064 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.07747974 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.01858691 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.01858691 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.01858691 |
| 8 | Peritonitis (HP:0002586) | 4.97393719 |
| 9 | Soft skin (HP:0000977) | 4.11445994 |
| 10 | Stomatitis (HP:0010280) | 3.93595105 |
| 11 | Shallow orbits (HP:0000586) | 3.90602607 |
| 12 | Amyloidosis (HP:0011034) | 3.77685712 |
| 13 | Dilatation of the ascending aorta (HP:0005111) | 3.74943158 |
| 14 | Aortic dissection (HP:0002647) | 3.71861467 |
| 15 | Biconcave vertebral bodies (HP:0004586) | 3.67881403 |
| 16 | Aortic aneurysm (HP:0004942) | 3.66576846 |
| 17 | Wormian bones (HP:0002645) | 3.46088335 |
| 18 | Ankle contracture (HP:0006466) | 3.44877830 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.43722353 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.43422744 |
| 21 | Abnormality of dentin (HP:0010299) | 3.40171943 |
| 22 | Atrophic scars (HP:0001075) | 3.40108876 |
| 23 | Spinal rigidity (HP:0003306) | 3.38993668 |
| 24 | Cervical subluxation (HP:0003308) | 3.34087297 |
| 25 | Cerebral aneurysm (HP:0004944) | 3.27859484 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.25931781 |
| 27 | Optic neuritis (HP:0100653) | 3.25931781 |
| 28 | Obstructive lung disease (HP:0006536) | 3.21917602 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 3.21917602 |
| 30 | T lymphocytopenia (HP:0005403) | 3.19126141 |
| 31 | Increased density of long bones (HP:0006392) | 3.18771519 |
| 32 | Increased IgM level (HP:0003496) | 3.15534916 |
| 33 | Osteolytic defects of the hand bones (HP:0009699) | 3.15007385 |
| 34 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.15007385 |
| 35 | Increased connective tissue (HP:0009025) | 3.12903480 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 3.10800035 |
| 37 | Short nail (HP:0001799) | 3.08684445 |
| 38 | Recurrent fungal infections (HP:0002841) | 3.04396790 |
| 39 | Petechiae (HP:0000967) | 3.03082248 |
| 40 | Recurrent skin infections (HP:0001581) | 3.01406369 |
| 41 | Abnormality of T cell number (HP:0011839) | 2.97468313 |
| 42 | Blue sclerae (HP:0000592) | 2.93365918 |
| 43 | Spinal cord lesions (HP:0100561) | 2.90698525 |
| 44 | Syringomyelia (HP:0003396) | 2.90698525 |
| 45 | Loss of speech (HP:0002371) | 2.89215923 |
| 46 | Fragile skin (HP:0001030) | 2.85567048 |
| 47 | Abnormal hemoglobin (HP:0011902) | 2.85134321 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.83088109 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.82847703 |
| 50 | Type 1 muscle fiber predominance (HP:0003803) | 2.82829723 |
| 51 | Vascular tortuosity (HP:0004948) | 2.79644380 |
| 52 | Meningitis (HP:0001287) | 2.79579590 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.76038369 |
| 54 | Purpura (HP:0000979) | 2.73110055 |
| 55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.72163726 |
| 56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.72163726 |
| 57 | Urticaria (HP:0001025) | 2.66616088 |
| 58 | Increased serum ferritin (HP:0003281) | 2.65077706 |
| 59 | Pustule (HP:0200039) | 2.64325577 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.63818206 |
| 61 | Gastrointestinal infarctions (HP:0005244) | 2.63171669 |
| 62 | Bladder diverticulum (HP:0000015) | 2.60868014 |
| 63 | Wrist flexion contracture (HP:0001239) | 2.59767942 |
| 64 | Beaking of vertebral bodies (HP:0004568) | 2.59418659 |
| 65 | Encephalitis (HP:0002383) | 2.59007623 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.58713955 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.57956335 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.57956335 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.57956335 |
| 70 | Elbow flexion contracture (HP:0002987) | 2.57025408 |
| 71 | Coxa vara (HP:0002812) | 2.55422723 |
| 72 | Follicular hyperkeratosis (HP:0007502) | 2.54863174 |
| 73 | Joint stiffness (HP:0001387) | 2.53904526 |
| 74 | Neonatal short-limb short stature (HP:0008921) | 2.52841569 |
| 75 | Vasculitis (HP:0002633) | 2.52008249 |
| 76 | Arterial tortuosity (HP:0005116) | 2.51389229 |
| 77 | Sparse lateral eyebrow (HP:0005338) | 2.50696373 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 2.50588198 |
| 79 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48670415 |
| 80 | Achilles tendon contracture (HP:0001771) | 2.48376189 |
| 81 | Genu recurvatum (HP:0002816) | 2.45941974 |
| 82 | Disinhibition (HP:0000734) | 2.44123924 |
| 83 | Keratoconjunctivitis sicca (HP:0001097) | 2.40282290 |
| 84 | Gingivitis (HP:0000230) | 2.38141446 |
| 85 | Recurrent viral infections (HP:0004429) | 2.37511136 |
| 86 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.36195794 |
| 87 | Progressive neurologic deterioration (HP:0002344) | 2.35562935 |
| 88 | Myocardial infarction (HP:0001658) | 2.34526718 |
| 89 | Abnormality of T cells (HP:0002843) | 2.33547468 |
| 90 | Hemoptysis (HP:0002105) | 2.32982560 |
| 91 | Abnormality of the acetabulum (HP:0003170) | 2.30941342 |
| 92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.30581614 |
| 93 | Myositis (HP:0100614) | 2.28242034 |
| 94 | Leukocytosis (HP:0001974) | 2.27627739 |
| 95 | Episodic fever (HP:0001954) | 2.27249461 |
| 96 | Keratoconjunctivitis (HP:0001096) | 2.26535490 |
| 97 | Epistaxis (HP:0000421) | 2.26399352 |
| 98 | Chest pain (HP:0100749) | 2.24596963 |
| 99 | Autoimmune hemolytic anemia (HP:0001890) | 2.24307914 |
| 100 | Increased IgE level (HP:0003212) | 2.23265602 |
| 101 | Dysostosis multiplex (HP:0000943) | 2.21638760 |
| 102 | Abnormality of the Achilles tendon (HP:0005109) | 2.21044248 |
| 103 | Orchitis (HP:0100796) | 2.17774600 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 2.16656798 |
| 105 | Multiple lipomas (HP:0001012) | 2.16603722 |
| 106 | Recurrent abscess formation (HP:0002722) | 2.16189533 |
| 107 | Hyperextensible skin (HP:0000974) | 2.15645987 |
| 108 | Eczematoid dermatitis (HP:0000976) | 2.12571883 |
| 109 | Distal lower limb amyotrophy (HP:0008944) | 2.11916042 |
| 110 | Overgrowth (HP:0001548) | 2.10140945 |
| 111 | Thin bony cortex (HP:0002753) | 2.09717018 |
| 112 | Scapular winging (HP:0003691) | 2.09161631 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 2.08325919 |
| 114 | Glomerulopathy (HP:0100820) | 2.08237962 |
| 115 | Abnormal delivery (HP:0001787) | 2.07594808 |
| 116 | Coronal craniosynostosis (HP:0004440) | 2.06829906 |
| 117 | Interstitial pulmonary disease (HP:0006530) | 2.06405284 |
| 118 | Spinal cord compression (HP:0002176) | 2.03851725 |
| 119 | Slender build (HP:0001533) | 2.03815943 |
| 120 | Distal upper limb amyotrophy (HP:0007149) | 2.02894828 |
| 121 | Upper limb amyotrophy (HP:0009129) | 2.02894828 |
| 122 | IgG deficiency (HP:0004315) | 2.02620103 |
| 123 | Granulocytopenia (HP:0001913) | 2.02559227 |
| 124 | Delayed cranial suture closure (HP:0000270) | 2.01903715 |
| 125 | Upper motor neuron abnormality (HP:0002127) | 2.01010532 |
| 126 | Trismus (HP:0000211) | 2.00307769 |
| 127 | Abnormality of the 2nd finger (HP:0004100) | 1.98740032 |
| 128 | Axonal loss (HP:0003447) | 1.97188369 |
| 129 | Mucopolysacchariduria (HP:0008155) | 1.95507455 |
| 130 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95507455 |
| 131 | Difficulty climbing stairs (HP:0003551) | 1.95357825 |
| 132 | Mutism (HP:0002300) | 1.95074084 |
| 133 | Anorexia (HP:0002039) | 1.94669977 |
| 134 | Gingival bleeding (HP:0000225) | 1.94435534 |
| 135 | Prolonged bleeding time (HP:0003010) | 1.93529595 |
| 136 | Distal lower limb muscle weakness (HP:0009053) | 1.93287535 |
| 137 | Mitral regurgitation (HP:0001653) | 1.93225519 |
| 138 | Inflammation of the large intestine (HP:0002037) | 1.93203405 |
| 139 | Acrocyanosis (HP:0001063) | 1.92492213 |
| 140 | Hypertensive crisis (HP:0100735) | 1.91214420 |
| 141 | Infantile muscular hypotonia (HP:0008947) | 1.91176008 |
| 142 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.90675506 |
| 143 | Mitral valve prolapse (HP:0001634) | 1.89877941 |
| 144 | Generalized amyotrophy (HP:0003700) | 1.88874467 |
| 145 | Broad metatarsal (HP:0001783) | 1.88582978 |
| 146 | Gangrene (HP:0100758) | 1.88231820 |
| 147 | Arthralgia (HP:0002829) | 1.87806051 |
| 148 | Vacuolated lymphocytes (HP:0001922) | 1.87241140 |
| 149 | Polyneuropathy (HP:0001271) | 1.86896013 |
| 150 | Abnormality of the pleura (HP:0002103) | 1.86750895 |
| 151 | Entropion (HP:0000621) | 1.85946644 |
| 152 | Spondylolisthesis (HP:0003302) | 1.85558105 |
| 153 | Hypertriglyceridemia (HP:0002155) | 1.84907376 |
| 154 | Thoracolumbar scoliosis (HP:0002944) | 1.84468119 |
| 155 | Basal ganglia calcification (HP:0002135) | 1.83644042 |
| 156 | Gastrointestinal inflammation (HP:0004386) | 1.82742539 |
| 157 | Prolonged neonatal jaundice (HP:0006579) | 1.82662872 |
| 158 | Broad face (HP:0000283) | 1.82633026 |
| 159 | Abnormality of the pericardium (HP:0001697) | 1.82105640 |
| 160 | Arterial thrombosis (HP:0004420) | 1.81372593 |
| 161 | Cellulitis (HP:0100658) | 1.81159041 |
| 162 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.80359598 |
| 163 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79650121 |
| 164 | Lymphopenia (HP:0001888) | 1.79415785 |
| 165 | Increased cerebral lipofuscin (HP:0011813) | 1.78581673 |
| 166 | Aplastic anemia (HP:0001915) | 1.78531383 |
| 167 | Decreased subcutaneous fat (HP:0001002) | 1.77983301 |
| 168 | Gastrointestinal dysmotility (HP:0002579) | 1.77070141 |
| 169 | Camptodactyly of toe (HP:0001836) | 1.76062567 |
| 170 | Recurrent bacterial skin infections (HP:0005406) | 1.72904160 |
| 171 | Buphthalmos (HP:0000557) | 1.70918681 |
| 172 | Natal tooth (HP:0000695) | 1.69947311 |
| 173 | Deviation of the hallux (HP:0010051) | 1.69525376 |
| 174 | Hand muscle atrophy (HP:0009130) | 1.69039107 |
| 175 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.68979635 |
| 176 | Hematochezia (HP:0002573) | 1.68722712 |
| 177 | Bowel diverticulosis (HP:0005222) | 1.68617872 |
| 178 | Radial bowing (HP:0002986) | 1.67657143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 6.75655107 |
| 2 | TESK2 | 4.39155317 |
| 3 | TESK1 | 3.98281048 |
| 4 | LIMK1 | 3.59311407 |
| 5 | TRIB3 | 3.22557897 |
| 6 | ERN1 | 3.07902571 |
| 7 | MAP4K1 | 2.99367967 |
| 8 | PIM2 | 2.92396480 |
| 9 | LATS2 | 2.87063929 |
| 10 | RIPK4 | 2.77390868 |
| 11 | TXK | 2.54700489 |
| 12 | RPS6KA4 | 2.48846995 |
| 13 | MOS | 2.35573901 |
| 14 | TTN | 2.32564155 |
| 15 | LRRK2 | 2.13877161 |
| 16 | DDR2 | 2.04164809 |
| 17 | PKN2 | 1.90657676 |
| 18 | FES | 1.88382165 |
| 19 | GRK7 | 1.88120559 |
| 20 | PBK | 1.83759604 |
| 21 | PRPF4B | 1.71931746 |
| 22 | IRAK4 | 1.67918963 |
| 23 | TRPM7 | 1.65608031 |
| 24 | ILK | 1.63768127 |
| 25 | BMX | 1.57832776 |
| 26 | GRK6 | 1.52232840 |
| 27 | MAP3K3 | 1.48798578 |
| 28 | SYK | 1.44812927 |
| 29 | BTK | 1.42527205 |
| 30 | IKBKE | 1.41783614 |
| 31 | ARAF | 1.39691323 |
| 32 | TBK1 | 1.38531535 |
| 33 | PAK2 | 1.35076887 |
| 34 | MAP3K11 | 1.30605281 |
| 35 | PIK3CG | 1.30115532 |
| 36 | BCKDK | 1.27910435 |
| 37 | TAOK2 | 1.24901751 |
| 38 | TLK1 | 1.20904919 |
| 39 | MAP3K12 | 1.20023855 |
| 40 | LYN | 1.18698080 |
| 41 | TAOK3 | 1.17872206 |
| 42 | ABL2 | 1.13904705 |
| 43 | MAP2K3 | 1.11002912 |
| 44 | TNK2 | 1.09966592 |
| 45 | PTK2B | 1.09210867 |
| 46 | LCK | 1.09070492 |
| 47 | VRK2 | 1.07861929 |
| 48 | ERBB3 | 1.05884873 |
| 49 | PDGFRA | 1.05657857 |
| 50 | BMPR2 | 1.04786064 |
| 51 | ITK | 1.04348871 |
| 52 | PAK4 | 1.02557699 |
| 53 | NEK9 | 0.98041096 |
| 54 | MATK | 0.97470328 |
| 55 | KDR | 0.97253459 |
| 56 | MYLK | 0.94077893 |
| 57 | TEC | 0.93791705 |
| 58 | KIT | 0.88521055 |
| 59 | IKBKB | 0.86616383 |
| 60 | TYK2 | 0.80279376 |
| 61 | STK3 | 0.80153584 |
| 62 | BLK | 0.79901597 |
| 63 | MAP3K8 | 0.79035769 |
| 64 | DAPK1 | 0.78458915 |
| 65 | MAP3K1 | 0.78218261 |
| 66 | EPHB1 | 0.76502629 |
| 67 | PAK1 | 0.75241385 |
| 68 | PRKG2 | 0.74935323 |
| 69 | MAPKAPK3 | 0.74132965 |
| 70 | ROCK1 | 0.73904345 |
| 71 | TAOK1 | 0.73427744 |
| 72 | JAK2 | 0.73398298 |
| 73 | SIK3 | 0.73145628 |
| 74 | JAK3 | 0.72856071 |
| 75 | PAK6 | 0.72703832 |
| 76 | CAMKK2 | 0.70654936 |
| 77 | MAP3K10 | 0.70023916 |
| 78 | TGFBR1 | 0.69404049 |
| 79 | DYRK1B | 0.65780559 |
| 80 | STK10 | 0.65444787 |
| 81 | DAPK3 | 0.63192824 |
| 82 | SCYL2 | 0.62795883 |
| 83 | PTK2 | 0.62630084 |
| 84 | CDK6 | 0.62109009 |
| 85 | MAP3K14 | 0.59370006 |
| 86 | MAPKAPK2 | 0.57292981 |
| 87 | MAP2K1 | 0.55541699 |
| 88 | HCK | 0.51448082 |
| 89 | CAMKK1 | 0.50774288 |
| 90 | CDK19 | 0.49627999 |
| 91 | HIPK2 | 0.49495772 |
| 92 | CDC42BPA | 0.49229320 |
| 93 | PTK6 | 0.48613917 |
| 94 | MAP3K13 | 0.48278841 |
| 95 | PRKCQ | 0.47987051 |
| 96 | FYN | 0.47525597 |
| 97 | PRKD1 | 0.46929168 |
| 98 | IRAK1 | 0.46194057 |
| 99 | CSK | 0.45723556 |
| 100 | ROCK2 | 0.44415358 |
| 101 | CDK14 | 0.43916299 |
| 102 | FRK | 0.43360415 |
| 103 | RPS6KA5 | 0.42644365 |
| 104 | PRKD2 | 0.42555265 |
| 105 | IRAK3 | 0.42317043 |
| 106 | MST1R | 0.41892580 |
| 107 | MAP3K5 | 0.41522862 |
| 108 | ADRBK2 | 0.41357311 |
| 109 | ACVR1B | 0.41048018 |
| 110 | CSF1R | 0.40431009 |
| 111 | AURKA | 0.39647964 |
| 112 | JAK1 | 0.39442135 |
| 113 | TGFBR2 | 0.38656292 |
| 114 | MET | 0.38644975 |
| 115 | PIM1 | 0.38537226 |
| 116 | MARK3 | 0.37718213 |
| 117 | MAPK7 | 0.37653904 |
| 118 | PDK1 | 0.37572470 |
| 119 | GRK5 | 0.36602965 |
| 120 | PAK3 | 0.35729895 |
| 121 | MAP3K6 | 0.35572021 |
| 122 | LMTK2 | 0.34690554 |
| 123 | FGR | 0.34550425 |
| 124 | PDPK1 | 0.34047064 |
| 125 | BRAF | 0.33539877 |
| 126 | EPHB2 | 0.33529272 |
| 127 | CDK15 | 0.32812912 |
| 128 | MAP2K6 | 0.32542197 |
| 129 | MAPKAPK5 | 0.31960423 |
| 130 | PRKCD | 0.31386503 |
| 131 | ABL1 | 0.30943388 |
| 132 | ZAP70 | 0.30687176 |
| 133 | BUB1 | 0.29665410 |
| 134 | RIPK1 | 0.29199080 |
| 135 | LATS1 | 0.28941003 |
| 136 | INSR | 0.28710029 |
| 137 | MAPK12 | 0.28438064 |
| 138 | DMPK | 0.28098071 |
| 139 | CDK18 | 0.27819987 |
| 140 | FER | 0.27518044 |
| 141 | AURKB | 0.27442267 |
| 142 | EIF2AK1 | 0.27406276 |
| 143 | FLT3 | 0.26962567 |
| 144 | CDK11A | 0.26774661 |
| 145 | RET | 0.26449084 |
| 146 | MAP2K2 | 0.25194935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.10558844 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.92753713 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.83815079 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.70685127 |
| 5 | Shigellosis_Homo sapiens_hsa05131 | 2.49362724 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.46736180 |
| 7 | Malaria_Homo sapiens_hsa05144 | 2.46718462 |
| 8 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.38995650 |
| 9 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.23731998 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.14468720 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98464390 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 1.85926375 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.85362249 |
| 14 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.85334961 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.76942588 |
| 16 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.76564518 |
| 17 | Apoptosis_Homo sapiens_hsa04210 | 1.75281708 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.74151644 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.69908569 |
| 20 | Focal adhesion_Homo sapiens_hsa04510 | 1.69608850 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.66962719 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.63011802 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.61863696 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.60634096 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.59376948 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58819010 |
| 27 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.53429588 |
| 28 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.52560725 |
| 29 | Bladder cancer_Homo sapiens_hsa05219 | 1.52386480 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.49277101 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49145986 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44289222 |
| 33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.40059997 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.34774305 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30448055 |
| 36 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.26109462 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25743584 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.23998743 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.22751977 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22253833 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 1.21807103 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20758178 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.13521653 |
| 44 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.10944070 |
| 45 | Melanoma_Homo sapiens_hsa05218 | 1.09569643 |
| 46 | Measles_Homo sapiens_hsa05162 | 1.08057549 |
| 47 | Proteasome_Homo sapiens_hsa03050 | 1.07753802 |
| 48 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.07712885 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06138652 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 1.06072249 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.04988060 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99592584 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99472903 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.97852132 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96164868 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95230227 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94935170 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94094719 |
| 59 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.94008418 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91104831 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.90638740 |
| 62 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.90286189 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90100149 |
| 64 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.87012666 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.86699748 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86026817 |
| 67 | Protein export_Homo sapiens_hsa03060 | 0.85865963 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.83326971 |
| 69 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83143446 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82257754 |
| 71 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.80696833 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80336179 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78800430 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78651012 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.76263969 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73919928 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73867279 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73110360 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72927419 |
| 80 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71998631 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71610047 |
| 82 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.71097156 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69845807 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69739118 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69446977 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.68690704 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.68011297 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64667251 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63672986 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63233805 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62709048 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.61194268 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.61175585 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59890613 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57889391 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.57292687 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55857391 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55166204 |
| 99 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55012529 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53480801 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51488137 |
| 102 | Parkinsons disease_Homo sapiens_hsa05012 | 0.50744747 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49273220 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49234426 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47518311 |
| 106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46668534 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45453421 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43909023 |
| 109 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42441333 |
| 110 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42264516 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42217600 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41567361 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41063906 |
| 114 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41039275 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.39963288 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39332146 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.38472508 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37211183 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35963976 |
| 120 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.34561271 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29961767 |
| 122 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27452390 |
| 123 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26014026 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21484555 |
| 125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18204000 |
| 126 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.16570776 |
| 127 | Huntingtons disease_Homo sapiens_hsa05016 | 0.14400334 |
| 128 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.12150733 |

